Derek T O'Hagan Selected Research

Vaccine Adjuvants

1/2021	Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.
1/2020	The continued advance of vaccine adjuvants - 'we can work it out'.
12/2011	The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
10/2007	MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Derek T O'Hagan Research Topics

Disease

13	Human Influenza (Influenza) 01/2023 - 01/2008
6	Whooping Cough (Pertussis) 02/2024 - 01/2011
6	COVID-19 07/2023 - 01/2020
5	Infections 01/2021 - 10/2007
5	Communicable Diseases (Infectious Diseases) 10/2020 - 06/2002
4	Malaria 08/2017 - 10/2007
4	Diphtheria 08/2016 - 01/2011
4	Tetanus 08/2016 - 01/2011
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 03/2009
2	Tuberculosis (Tuberculoses) 01/2021 - 07/2004
2	Hepatitis B 08/2017 - 01/2011
2	Inflammation (Inflammations) 10/2016 - 11/2014
2	Neoplasms (Cancer) 04/2003 - 06/2002
1	Meningococcal Infections 02/2024
1	Vesicular Stomatitis 10/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2017
1	Poliomyelitis (Polio) 01/2011
1	Measles 04/2008
1	Parasitemia 10/2007
1	Chronic Disease (Chronic Diseases) 10/2007
1	Anthrax 02/2005
1	Meningococcal Meningitis 02/2004

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 02/2024 - 06/2002
11	AntigensIBA 10/2020 - 02/2004
4	EmulsionsIBA 01/2023 - 04/2011
4	Vaccine AdjuvantsIBA 01/2021 - 10/2007
4	AntibodiesIBA 01/2017 - 08/2011
3	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021 - 10/2007
3	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 08/2011
3	MF59 oil emulsionIBA 08/2011 - 10/2007
2	AluminumIBA 07/2023 - 08/2015
2	Neutralizing AntibodiesIBA 01/2021 - 01/2008
2	aluminum sulfate (alum)IBA 01/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2017 - 02/2005
2	DNA VaccinesIBA 04/2008 - 07/2004
1	Recombinant ProteinsIBA 02/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023
1	alpha-Tocopherol FDA Link 01/2023
1	mRNA VaccinesIBA 02/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	AminesIBA 01/2019
1	Mannose (D-Mannose)IBA 01/2019
1	CholesterolIBA 01/2019
1	AerosolsIBA 01/2017
1	LigandsIBA 10/2016
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 10/2016
1	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 08/2016
1	Aluminum Hydroxide (Algeldrate)FDA Link 02/2016
1	Combined VaccinesIBA 02/2016
1	SaltsIBA 08/2015
1	pertactin FDA Link 08/2015
1	Pertussis ToxinIBA 08/2015
1	Excipients (Suspending Agents)IBA 06/2015
1	AIDS VaccinesIBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 04/2015
1	Immunoglobulins (Immunoglobulin)IBA 04/2015
1	env Gene ProductsIBA 04/2015
1	Immunoglobulin A (IgA)IBA 04/2014
1	Toll-Like Receptor AgonistsIBA 12/2011
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2011
1	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2009
1	Antiviral Agents (Antivirals)IBA 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Malaria VaccinesIBA 10/2007
1	Interferon-gamma (Interferon, gamma)IBA 10/2007
1	CPG-oligonucleotideIBA 02/2005

Therapy/Procedure

2	Injections 01/2011 - 10/2007
1	Microspheres (Microsphere) 02/2016
1	Transjugular Intrahepatic Portasystemic Shunt 06/2015